Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis

NCT07215494 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07215494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 15, 2025
Completion date
September 30, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

light chain (al) amyloidosis, mrd